314
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

, , , &
Pages 4077-4088 | Published online: 27 Jul 2012

References

  • KimISJeongYIKimDHLeeYHSung-Ho KimSHAlbumin release from biodegradable hydrogels composed of dextran and poly(ethylene glycol) macromerArch Pharm Res200124697311235815
  • PeppasNAKhareARPreparation, structure and diffusional behavior of hydrogels in controlled releaseAdv Drug Deliv Rev199311135
  • PeppasNABuresPLeobandungWIchikawaHHydrogels in pharmaceutical formulationsEur J Pharm Biopharm200050274610840191
  • BrazelCSPeppasNAMechanisms of solute and drug transport in relaxing, swellable, hydrophilic glassy polymersPolymer19994033833398
  • SiegalRAFirestoneBNAPH-Dependent equilibrium swelling properties of hydrophobic polyelectrolyte copolymer gelsMacromolecules19882132543259
  • NairKLJagadeeshanSNairSAKumarGSVBiological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGAInt J Nanomedicine201161685169721980233
  • NairKLJagadeeshanSNairSAKumarGSVEvaluation of triblock copolymeric micelles of δ-Valerolactone and poly(ethylene glycol) as a competent vector for doxorubicin delivery against cancerJ Nanobiotechno2011942
  • GanderBGurryRDoelkerPeppasNAEffect of polymeric network structure on drug release from crosslinked poly (vinyl alcohol) micromatricesPharm Res198965785842508077
  • ColomboPSantiPBettiniRBrazelCSDrug release from swelling-controlled systemsWiseDHandbook of Pharmaceutical Controlled Release TechnologyNew YorkMarcel Dekker2000183209
  • Brannon-PeppasLRecent advances in the use of biodegradable microparticles and nanoparticles in controlled drug deliveryInt J Pharm199511619
  • KostJLangerREquilibrium swollen hydrogels in controlled release applicationsPeppasNAHydrogels in Medicine and PharmacyBoca RatonCRC Press1986395108
  • KimBLa FlammeKPeppasNADynamic swelling behavior of pH-sensitive anionic hydrogels uses for protein deliveryJ Appl Polym Sci20038916061613
  • KhareARPeppasNASwelling/deswelling of anionic copolymer gelsBiomaterials1995165595677492721
  • LinCCMettersATHydrogels in controlled release formulations: network design and mathematical modellingAdv Drug Delivery Rev20065813791408
  • BurugapalliKBhatiaDKoulVChoudharyVInterpenetrating polymer networks based on poly(acrylic acid) and gelatin I: swelling and thermal behaviorJ Appl Polym Sci200182217227
  • HennickWEvan NostrumCFNovel cross linking methods to design hydrogelsAdv Drug Delivery Rev2002541326
  • GoelAKunnumakkaraABAggarwalBBCurcumin as “Curecumin”: from kitchen to clinicBiochem Pharmacol20087578780917900536
  • ShishodiaSSethiGAggarwalBBCurcumin: getting back to the rootsAnn N Y Acad Sci2005105620621716387689
  • StrimpakosASSharmaRACurcumin: preventive and therapeutic properties in laboratory studies and clinical trialsAntioxid Redox Sign200810511546
  • AnandPSundaramCJhuraniSKunnumakkaraABAggarwalBBCurcumin and cancer: an “old-age” disease with an “age-old” solutionCancer Lett200826713316418462866
  • ChuangSEKuoMLHsuCHCurcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesisCarcinogenesis20002133110657978
  • InanoHOnodaMInafukuNChemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with {gamma}-raysCarcinogenesis199920101110357781
  • KawamoriTLubetRSteeleVEChemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancerCancer Res1999595979973206
  • LiNChenXLiaoJInhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcuminCarcinogenesis200223130712151348
  • SinghSVHuXSrivastavaSKMechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcuminCarcinogenesis19981913579744529
  • VanderhoffJWBranfordEBTarkowskiHLInverse emulsion polymerizationAdv Chem Ser1962343251
  • QiuYParkKEnvironment-sensitive hydrogels for drug deliveryAdv Drug Delivery Rev200153321339
  • AntoRJVenkatramanMKarunagaranDInhibition of NF-kappaB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistanceJ Biol Chem2003278254902549812714587
  • PuliyappadambaVTCheriyanVTThulasidasanAKTNicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independentMolecular Cancer2010922020727180
  • SreekanthCNBavaSVSreekumarEAntoRJMolecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancerOncogene2011303139315221317920
  • Simbulan-RosenthalCMRosenthalDSIyerSBoularesAHSmulsonMETransient poly(ADP-ribosyl) ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosisJ Biol Chem1998273137039593711
  • BavaSVPuliappadambaVTDeeptiANairAKarunagaranDAntoRJSensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerizationJ Biol Chem20052806301630815590651
  • AggarwalBBSungBPharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends in Pharmacol Sci200930859419110321
  • MosesMABremHLangerRNovel delivery systems in cancer chemotherapySci Med20039264273
  • MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release20006527128410699287
  • PerraultSDWalkeyCJenningsTFischerHCChanWCMediating tumor targeting efficiency of nanoparticles through designNano Lett200991909191519344179
  • MohantyCSahooSKThe in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulationBiomaterials2010316597661120553984